Investigating Causal Associations of Diet-Derived Circulating Antioxidants with Risk of Six Major Mental Disorders: A Mendelian Randomization Study
Hao Zhao,Xue Han,Lingjiang Li,Xuening Zhang,Yuhua Liao,Huimin Zhang,Wenyan Li,Jingman Shi,Wenjian Lai,Wanxin Wang,Roger S. McIntyre,Kayla M. Teopiz,Lan Guo,Ciyong Lu
DOI: https://doi.org/10.1101/2022.05.11.22274935
2022-01-01
Abstract:Background Observational studies have suggested associations between circulating antioxidant levels and many mental disorders, but evidence from randomized controlled trials (RCTs) is lacking and causal inferences have not been confirmed. The aim of this study was to explore whether genetically predicted diet-derived circulating antioxidants were causally associated with the risk of major mental disorders using Mendelian randomization (MR).
Methods and findings We performed 2-sample MR analyses of summary-level genetic data to explore whether diet-derived circulating antioxidants [e.g., vitamins E (α- and γ-tocopherol), ascorbate, retinol, β-carotene, and lycopene], assessed by absolute circulating antioxidants and relative circulating antioxidant metabolites, were causally associated with the risk of six major mental disorders, including major depressive disorder (MDD), schizophrenia (SCZ), bipolar disorder (BIP), autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). The inverse-variance weighted method was adopted as primary MR analyses and five additional MR methods (likelihood-based MR, MR-Egger, weighted median, penalized weighted median, and MR-PRESSO) and different outcome databases were used for sensitivity analyses. We found suggestive evidence that genetically predicted higher absolute circulating α-tocopherol levels marginally reduced the risk of SCZ, with the odds ratio (OR) per unit increase in log-transformed α-tocopherol values was 0.71 [95% confidence interval (CI) 0.54 to 0.94; P = 0.016]. However, after adjusting for multiple testing (threshold of P < 0.008), we found no significant evidence that genetically predicted higher diet-derived absolute circulating antioxidant levels and antioxidant metabolites concentrations were significantly causally associated with the six-foregoing major mental disorders.
Conclusions Overall, our study does not support significant causal associations of genetically predicted diet-derived circulating antioxidants with the risk of major mental disorders. Therefore, simply taking antioxidants to increase blood antioxidants levels is unlikely to have a significant protective effect on the prevention of most mental disorders.
Why was this study done? Some observational studies have reported that diet-derived circulating antioxidants are associated with a reduced risk of major mental disorders; however, these studies are susceptible to uncertain temporal relationships, insufficient sample sizes, or potential confounding factors, and thus it remains unclear whether these associations are accurate.
To our knowledge, there are no randomized clinical trials published to date on this topic. Since oxidative stress is closely related to the occurrence of mental diseases, if diet-derived circulating antioxidants can reduce the risk of major mental disorders, it will be an interesting target as primary prevention of mental disorders.
What did the researchers do and find? We performed a Mendelian randomization study design to explore whether genetically predicted diet-derived circulating antioxidants [e.g., vitamins E (α- and γ-tocopherol), ascorbate, retinol, β-carotene, and lycopene], assessed by absolute circulating antioxidants and relative circulating antioxidant metabolites, were causally associated with the risk of six major mental disorders, including major depressive disorder, schizophrenia, bipolar disorder, autism spectrum disorder, attention- deficit/hyperactivity disorder, and post-traumatic stress disorder.
Overall, our study provides suggestive evidence that genetically predicted higher absolute α-tocopherol levels may be causally associated with a reduced risk of schizophrenia. However, our study did not find genetically predicted significant causal associations of dietary antioxidants with major mental disorders after correction for multiple testing.
What do these findings mean? Our findings suggest for healthy adults without nutritional deficiency, simply taking antioxidants to increase blood antioxidants levels is unlikely to have a significant protective effect on the prevention of most mental disorders.
In the future, large-scale GWASs are needed to further validate our current findings, especially the suggestive protective effect of higher α-tocopherol levels on schizophrenia, by utilizing additional genetic variants and more samples.
### Competing Interest Statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Roger McIntyre has received research grant support from CIHR/GACD/National Natural Science Foundation of China (NSFC) speaker/consultation fees from Lundbeck, Janssen, Alkermes, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Sunovion, Bausch Health, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Abbvie, Atai Life Sciences. Dr. Roger McIntyre is a CEO of Braxia Scientific Corp. Kayla M. Teopiz has received personal fees from Braxia Scientific Corp. All other authors have no conflicts of interest to disclose.
### Funding Statement
The author(s) received no specific funding for this work.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Because all analyses here in are based on publicly available summary data, no ethical approval from an institutional review boardwas required for this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
All relevant data are within the manuscript and its Supporting Information files. The summary-level data for diet-derived circulating antioxidants are available at the corresponding original study (see References 23-29). The summary-level data for six major mental disorders are available at the Psychiatric Genomics Consortium (PGC) website (<https://www.med.unc.edu/pgc/results-and-downloads/>).
<https://www.med.unc.edu/pgc/results-and-downloads/>
* ADHD
: attention-deficit/hyperactivity disorder
ASD
: autism spectrum disorder
BIP
: bipolar disorder
CI
: confidence interval
GWAS
: genome-wide association studies
IVW
: inverse-variance weighted
LD
: linkage disequilibrium
MDD
: major depressive disorder
MR
: Mendelian randomization
OR
: odds ratio
PGC
: Psychiatric Genomics Consortium
PTSD
: post-traumatic stress disorder
RCTs
: randomized clinical trials
SCZ
: schizophrenia
SNPs
: single nucleotide polymorphisms